Somatostatin

New England Journal of Medicine

Volumn 309, Issue 24, 1983, Pages 1495-1501

  Reichlin, Seymour ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN; GROWTH HORMONE; THYROTROPIN;

DRUG THERAPY; ENDOCRINE SYSTEM; HUMAN; SHORT SURVEY; SURVEY; THERAPY; ANIMAL; BIOSYNTHESIS; BRAIN CORTEX; HYPOPHYSIS; INTESTINE; PANCREAS; PERIPHERAL NERVE; PHYLOGENY; PHYSIOLOGY; REVIEW; STOMACH; TRANSPORT AT THE CELLULAR LEVEL;

ANIMAL; BIOLOGICAL TRANSPORT; CEREBRAL CORTEX; GROWTH HORMONE; HUMAN; INTESTINES; PANCREAS; PERIPHERAL NERVES; PHYLOGENY; PITUITARY GLAND; SOMATOSTATIN; STOMACH; SUPPORT, U.S. GOV'T, P.H.S.; THYROTROPIN;

EID: 0021105680     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198312153092406     Document Type: Review

References (93)

1. Krulich L, Dhariwal APS, McCann SM. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 1968; 83: 783–790.
2. Hellman B, Lernmark Å. Inhibition of the in vitro secretion of insulin by an extract of pancreatic α1, cells. Endocrinology 1969; 84: 1484–1487.
3. Brazeau P. Vale W, Burgus R, et al., Hypothalamic peptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179: 77–79.
4. Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982; 218: 585–587.
5. Rivier J, Speiss J, Thorner M, Vale W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 1982; 300: 276–278.
6. Goodman RH, Jacobs JW, Dee PC, Habener JF. Somatostatin-28 encoded in a cloned cDNA obtained from a rat medullary thyroid carcinoma. J Biol Chem 1982; 257: 1156–1159.
7. Gerich JE. Somatostatin. In: Brownlee M, ed. Handbook of diabetes mellitus. Vol. 1. New York: Garland STPM Press, 1981:297–354.
8. McCann SM. Krulich L, Negro-Vilar A, Ojeda SR, Vijayan E. Regulation and function of panhibin (somatostatin). Adv Biochem Psychopharmacol 1980; 22: 131–143.
9. Reichlin S. Systems for the study of regulation of neuropeptide secretion. Adv Biochem Psychopharmacol 1981; 28: 573–597.
10. Morley JE. Neuroendocrine control of thyrotropin secretion. Endocr Rev 1981; 2: 396–436.
11. Gerich JE. Somatostatin and diabetes. Am J Med 1981; 70: 619–626.
12. Arimura A, Fishback JB. Somatostatin: regulation of secretion. Neuroendocrinology 1981; 33: 246–256.
13. Miller RE. Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocr Rev 1981; 2: 471–494.
14. Gottesman IS. Mandarino LJ, Gerich JE. Somatostatin. In: Cohen M, Foa P, eds. Special topics in endocrinology and metabolism. Vol. 4. New York, Alan R. Liss, 1982:177–243.
15. Reichlin S. Somatostatin in the nervous system. In: Bloom FE. Bird S, Schmitt FO, eds. Molecular genetic neuroscience. New York: Raven Press, 1982:359–372.
16. Idem. Somatostatin. In: Krieger DT, Brownstein M, Martin JB, eds. Brain peptides. New York: John Wiley, 1982:712–752.
17. Vale W, Ling N, River J, et al., Anatomic and phylogenetic distribution of somatostatin. Metabolism 1976; 25: Supplement 1: 1491–1494.
18. Falkmer S, Eide RP, Hellerström C, Petersson B. Phylogenetic aspects of somatostatin in the gastroenteropancreatic endocrine system. Metabolism 1978; 27: Supplement 1: 1193–1196.
19. Jackson IMD. Phylogenetic distribution and function of the hypophysiotropic hormones of the hypothalamus. Am Zoologist 1978; 18: 385–399.
20. Berelowitz M, LeRoith D, von Schenk H, et al., Somatostatin-like immunoactivity and biological activity is present in Tetrahymena pyriformis, a ciliated protozoan. Endocrinology 1982; 110: 1939–1944.
21. Roth J, LeRoith D, Shiloach J, Rosenzweig JL, Lesniak MA, Havrankova J. The evolutionary origins of hormones, neurotransmitters, and other extracellular chemical messengers: implications for mammalian biology. N Engl J Med 1982; 306: 523–527.
22. Hobart P, Crawford R, Shen L, Pictet R, Rutter WJ. Cloning and sequence analysis of cDNAs encoding two distinct somatostatin precursors found in the endocrine pancreas of anglerfish. Nature 1980; 288: 137–141.
23. Warren TG, Shields D. Cell-free biosynthesis of somatostatin precursors: evidence for multiple forms of preprosomatostatin. Proc Natl Acad Sci USA 1982; 79: 3729–3733.
24. Shen L-P, Pictet RL, Rutter WJ. Human somatostatin I: sequence of the cDNA. Proc Natl Acad Sci USA 1982; 79: 4575–4579.
25. Guillemin R. The brain as an endocrine organ. Neurosci Res Program Bull 1978; 16: Supplement: 1–25.
26. Alpert LC, Brawer JR, Patel YC, Reichlin S. Somatostatinergic neurons in anterior hypothalamus: immunohistochemical localization. Endocrinology 1976; 98: 255–258.
27. Knigge KM, Joseph SA, Hoffman GE. Organization of LRF- and SRIF-neurons in the endocrine hypothalamus. In: Reichlin S, Baldessarini RJ, Martin JB, eds. The hypothalamus. New York: Raven Press, 1978:49–67.
28. Hökfelt T, Eide R, Fuxe K, et al., Aminergic and peptidergic pathways in the nervous system with special reference to the hypothalamus. In: Reichlin S, Baldessarini RJ, Martin JB, eds. The hypothalamus. New York: Raven Press, 1978:69–135.
29. Krisch B. Hypothalamic and extrahypothalamic distribution of somatostatin-immunoreactive elements in the rat brain. Cell Tissue Res 1978; 195: 499–513.
30. Pelletier G. Immunohistochemical localization of somatostatin. Prog Histochem Cytochem 1980; 12 (3): 1–41.
31. Bennett-Clarke C, Romagnano MA, Joseph SA. Distribution of somatostatin in the rat brain: telencephalon and diencephalon. Brain Res 1980; 188: 473–486.
32. Krisch B. Somatostatin-immunoreactive fiber projections into the brain stem and the spinal cord of the rat. Cell Tissue Res 1981; 217: 531–552.
33. Hökfelt T, Johansson O, Ljungdahl Å., Lundberg JM, Schultzberg M. Peptidergic neurones. Nature 1980; 284: 515–521.
34. Hökfelt T, Elfvin LG, Eide R, Schultzberg M, Goldstein M, Luft R. Occurrence of somatostatin-like immunoreactivity in some peripheral sympathetic noradrenergic neurons. Proc Natl Acad Sci USA 1977; 74: 3587–3591.
35. Lundberg JM. Hökfelt T, Nilsson G, et al., Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta Physiol Scand 1978; 104: 499–501.
36. Takatsuki K, Shiosaka S, Sakanaka M, et al., Somatostatin in the auditory system of the rat. Brain Res 1981; 213: 211–216.
37. Rorstad OP, Brownstein MJ, Martin JB. Immunoreactive and biologically active somatostatin-like material in rat retina. Proc Natl Acad Sci USA 1979; 76: 3019–3023.
38. Yamada T, Marshak D, Basinger S, Walsh J, Morley J, Stell W. Somatostatin-like immunoreactivity in the retina. Proc Natl Acad Sci USA 1980; 77: 1691–1695.
39. Laemle LK, Feldman SC, Lichtenstein E. Somatostatin-like immunoreactivity in the rodent visual system. Presented at the 11th annual meeting of the Society for Neuroscience, Los Angeles, October 18–23, 1981.
40. Krisch B. Differing immunoreactivities of somatostatin in the cortex and the hypothalamus of the rat: a light and electron microscope study. Cell Tissue Res 1980; 212: 457–464.
41. Patel YC, Reichlin S. Somatostatin in hypothalamus, extrahypothalamic brain, and peripheral tissues of the rat. Endocrinology 1978; 102: 523–530.
42. Epelbaum J, Willoughby JO, Brazeau P, Martin JB. Effects of brain lesions and hypothalamic deafferentation on somatostatin distribution in the rat brain. Endocrinology 1977; 101: 1495–1502.
43. Delfs J, Robbins R, Connolly JL, Dichter M, Reichlin S. Somatostatin production by rat cerebral neurones in dissociated cell culture. Nature 1980; 283: 676–677.
44. Robbins RJ, Sutton RE, Reichlin S. Sodium- and calcium-dependent somatostatin release from dissociated cerebral cortical cells in culture. Endocrinology 1982; 110: 496–499.
45. Robbins RJ. Effects of neurotransmitters and cyclic AMP on somatostatin release from cultured cerebral cortical cells. Brain Res 1982; 234: 377–386.
46. Solcia E, Pollack JM, Pearse AGE, et al., Lausanne 1977 Classification of gastroentero-pancreatic endocrine cells. In: Bloom SR, ed. Gut hormones. Edinburgh: Churchill Livingstone, 1978:40–48.
47. Dubois M. Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas. Proc Natl Acad Sci USA 1975; 72: 1340–1343.
48. Orci L, Baetens D, Dubois MP, Rufener C. Evidence for the D-cell of the pancreas secreting somatostatin. Horm Metab Res 1975; 7: 400–402.
49. Polak J, Pearse AGE, Grimelius L, Bloom S, Arimura A. Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet 1975; 1: 1220–1222.
50. Kawai K, Ipp E, Orci L, Perrelet A, Unger RH. Circulating somatostatin acts on the islets of Langerhans by way of a somatostatin-poor compartment. Science 1982; 218: 477–478.
51. Arnold R, Lankisch PG. Somatostatin and the gastrointestinal tract. Clin Gastroenterol 1980; 9: 733–753.
52. Larsson L-I. Gastrointestinal cells producing endocrine, neurocrine and paracrine messengers. Clin Gastroenterol 1980; 9: 485–516.
53. Sundler F, Håkanson R, Leander S. Peptidergic nervous systems in the gut. Clin Gastroenterol 1980; 9: 517–543.
54. Girod C, Dubois MP, Durand N. Immunocytochemical evidence for the presence of somatostatin-like immunoreactivity in scattered cells of the duct system of the submandibular glands in the monkey, Macaca irus. Histochemistry 1980; 69: 137–143.
55. Molnar J, Arimura A, Kastin AJ. Presence of immunoreactive somatostatin in the salivary gland and saliva. Fed Proc 1976; 35: 782. abstract.
56. Van Noorden S, Polak JM, Pearse AGE. Single cellular origin of somatostatin and calcitonin in the rat thyroid gland. Histochemistry 1977; 53: 243–247.
57. Yamada Y, Ito S, Matsubara Y, Kobayashi S. Immunohistochemical demonstration of somatostatin-containing cells in the human, dog and rat thyroids. Tohoku J Exp Med 1977; 122: 87–92.
58. Sundler F, Alumets J, Håkanson R, Björklund L, Ljungberg O. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid. Am J Pathol 1977; 88: 381–385.
59. Birnbaum RS, Muszynski M, Ross BA. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma. Cancer Res 1980; 40: 4192–4196.
60. Gordin A, Lamberg B-A, Pelkonen R, Almqvist S. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid. Clin Endocrinol (Oxf) 1978; 8: 289–293.
61. Bolaffi JL, Reichlin S, Goodman DBP, Forrest JN Jr. Somatostatin: occurrence in urinary bladder epithelium and renal tubules of the toad, Bufo marinus. Science 1980; 210: 644–646.
62. Kronheim S, Berelowitz M, Primstone BL. The characterization of growth hormone release inhibiting hormone-like immunoreactivity in normal urine. Clin Endocrinol (Oxf) 1977; 7: 343–347.
63. Reid IA, Rose JC. An intrarenal effect of somatostatin on water excretion. Endocrinology 1977; 100: 782–785.
64. Forrest JN Jr., Reichlin S, Goodman DBP. Somatostatin: an endogenous peptide in the toad urinary bladder inhibits vasopressin-stimulated water flow. Proc Natl Acad Sci USA 1980; 77: 4984–4987.
65. Gomez-Pan A, Snow M, Piercy D, et al., Actions of growth hormone-release inhibiting hormone (somatostatin) on the renin aldosterone system. J Clin Endocrinol Metab 1976; 43: 240–243.
66. Rosenthal J, Raptis S, Escobar-Jimenez F, Pfeiffer E. Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man. Lancet 1976; 1: 772–774.
67. Shields D, Warren TG, Green RF, Roth SE, Brenner MJ. The primary events in the biosynthesis and post-translational processing of different precursors to somatostatin. In: Rich DH, Gross E, eds. Peptides: synthesis-structure-function: proceedings of the seventh American Peptide Symposium. Rockford, Ill. Pierce Chemical Company, 1981:471–479.
68. Zingg HH, Patel YC. Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture. J Clin Invest 1982; 70: 1101–1109.
69. Rorstad OP, Epelbaum J, Brazeau P, Martin JB. Chromatographic and biological properties of immunoreactive somatostatin in hypothalamic and extrahypothalamic brain regions of the rat. Endocrinology 1979; 105: 1083–1092.
70. Mandarino L, Stenner D, Blanchard W, et al., Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature 1981; 291: 76–77.
71. Meyers CA, Murphy WA, Redding TW, Coy DH, Schally AV. Synthesis and biological actions of prosomatostatin. Proc Natl Acad Sci USA 1980; 77: 6171–6174.
72. Konturek SJ, Tasler J, Jaworek J, et al., Gastrointestinal secretory, motor, circulatory, and metabolic effects of prosomatostatin. Proc Natl Acad Sci USA 1981; 78: 1967–1971.
73. Brown M, Speiss J, Reubi JC, Perrin M, Vale W. Somatostatin -28 (SS 28), somatostatin-14 (SS 14) and their analogs: comparative biologic actions. Presented at the 63rd annual meeting of the Endocrine Society, Cincinnati, June 17–19, 1981.
74. Rasool CG, Schwartz AL, Bollinger JA, Reichlin S, Bradley WG. Immunoreactive somatostatin distribution and axoplasmic transport in rat peripheral nerve. Endocrinology 1981; 108: 996–1001.
75. Martin JB, Brazeau P, Tannenbaum GS, et al., Neuroendocrine organization of growth hormone regulation. In: Reichlin S, Baldessarini RJ, Martin JB, eds. The hypothalamus. New York: Raven Press, 1978:329–351.
76. Terry LC, Martin JB. The effects of lateral hypothalamic-medial forebrain stimulation and somatostatin antiserum on pulsatile growth hormone secretion in freely behaving rats: evidence for a dual regulatory mechanism. Endocrinology 1981; 109: 622–627.
77. Arimura A, Smith W, Schally AV. Blockade of the stress-induced decrease in blood GH by anti-somato statin serum in rats. Endocrinology 1976; 98: 540–543.
78. Ferland L, Labrie F, Jobin M, Arimura A, Schally AV. Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem Biophys Res Commun 1976; 68: 149–156.
79. Terry LC, Willoughby JO, Brazeau P, Martin JB, Patel Y. Antiserum to somatostatin prevents stress-induced inhibition of growth hormone secretion in the rat. Science 1976; 192: 565–566.
80. Tannenbaum GS, Epelbaum J, Colle E, Brazeau P, Martin JB. Antiserum to somatostatin reverses starvation-induced inhibition of growth hormone but not insulin secretion. Endocrinology 1978; 102: 1909–1914.
81. Wehrenberg WB, Ling N, Böhlen P, Esch F, Brazeau P, Guillemin R. Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. Biochem Biophys Res Commun 1982; 109: 562–567.
82. Martin JB, Reichlin S. Clinical neuroendocrinology. 2nd ed. Philadelphia: FA Davis (in press).
83. Tannenbaum GS. Evidence for autoregulation of growth hormone secretion via the central nervous system. Endocrinology 1980; 107: 2117–2120.
84. Abe H, Molitch ME, van Wyk JJ, Underwood LE. Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology 1983; 113: 1319–1324.
85. Berelowitz M, Firestone SL, Frohman LA. Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution. Endocrinology 1981; 109: 714–719.
86. Sheppard MC, Kronheim S, Primstone BL. Stimulation by growth hormone of somatostatin release from the rat hypothalamus in vitro. Clin Endocrinol (Oxf) 1978; 9: 583–586.
87. Chihara K, Minamitani N, Kaji H, Arimura A, Fujita T. Intraventricularly injected growth hormone stimulates somatostatin release into rat hypophysial portal blood. Endocrinology 1981; 109: 2279–2281.
88. Berelowitz M, Szabo M, Frohman L.A., Firestone S, Chu L., Hintz R.L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 1981; 212: 1279–1281.
89. Vale W, Rivier C, Brazeau P, Guillemin R. Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology 1975; 95: 968–977.
90. Chihara K, Arimura A, Chihara M, Schally AV. Studies on the mechanism of growth hormone and thyrotropin responses to somatostatin antiserum in anesthetized rats. Endocrinology 1978; 103: 1916–1923.
91. Weeke J, Hansen AP, Lundaek K. Inhibition by somatostatin of basal levels of serum thyrotropin in normal men. J Clin Endocrinol Metab 1975; 41: 168–171.
92. Lucke C, Höffken B, von zue Mühlen A. The effect of somatostatin on TSH levels in patients with primary hypothyroidism. J Clin Endocrinol Metab 1975; 41: 1082–1084.
93. Berelowitz M, Maeda K, Harris S, Frohman LA. The effect of alterations in the pituitary-thyroid axis on hypothalamic content and in vitro release of somatostatin-like immunoreactivity. Endocrinology 1980; 107: 24–29.